Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2025-10-30 00:00:00 ET · period of report 2025-10-28 · accession 0001763494-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-30 | 2025-10-28+ | TVTX | Dube Eric M | CEO, Dir | S - Sale+OE | $30.32 | -120.0K | 419.2K | -22% | -$3.64M |
| DM | 2025-10-30 | 2025-10-28+ | TVTX | Dube Eric M | CEO, Dir | M - OptEx | $15.46 | +120.0K | 446.3K | +37% | +$1.86M |
| DM | 2025-10-30 | 2025-10-28+ | TVTX | Dube Eric M | CEO, Dir | M - OptEx | $0.00 | -120.0K | 207.1K | -37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-28 | S | D | 92,872 | $30.38 | 419,173 | D | — | — | (F2) The weighted average sale price for the transaction reported was $30.379, and the range of prices were between $30.00 and $30.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. |
| 2 | Common | Common Stock | 2025-10-28 | M | A | 92,872 | $15.46 | 512,045 | D | — | — | |
| 3 | Common | Common Stock | 2025-10-29 | S | D | 27,128 | $30.12 | 419,173 | D | — | — | (F3) The weighted average sale price for the transaction reported was $30.1192, and the range of prices were between $30.00 and $30.48. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. |
| 4 | Common | Common Stock | 2025-10-29 | M | A | 27,128 | $15.46 | 446,301 | D | — | — | |
| 5 | Derivative | Employee stock option (right to buy) | 2025-10-29 | M | D | 27,128 | $0.00 | 180,000 | D | $15.46 · — to 2030-01-31 | 27,128 Common Stock | (F4) The stock option is fully vested and exercisable. |
| 6 | Derivative | Employee stock option (right to buy) | 2025-10-28 | M | D | 92,872 | $0.00 | 207,128 | D | $15.46 · — to 2030-01-31 | 92,872 Common Stock | (F4) The stock option is fully vested and exercisable. |